NIH Director’s New Innovator Awards (DP2)

To support highly innovative research projects by new investigators in all areas of biomedical and behavioral research.

Purpose

Part of the High-Risk, High-Reward Research program, the award supports early career investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the NIH mission.

Special Considerations

Organization Eligibility

  • Eligibility: U.S. domestic institutions

Carefully read the Eligibility section of the funding opportunity for opportunity-specific organization eligibility requirements.

Project Director/ Principal Investigator (PD/PI) Eligibility

  • Career Stage: Early Career

Early Stage Investigator (ESI)

Carefully read the Eligibility section of the funding opportunity for opportunity-specific PD/PI eligibility requirements.

Award Information

  • Funding Instrument: Grant
  • Funding Category: Research and Development
  • Budget Mechanism Code: RP - Research Projects
  • Multi-year Funded: Yes

NIH Director’s New Innovator Awards (DP2)
Active Funding Opportunities
The NIH Guide for Grants and Contracts is NIH's official publication of notices of grant policies, guidelines, and funding opportunities.
Search Now

Due Dates

The Key Dates section of funding opportunities lists specific due dates. Many opportunities indicate Standard Due Dates apply.

Standard Application Due Dates (when applicable) Review and Award Cycles
New Renewal, Resubmission,
Revision as Allowed		 AIDS and AIDS Related
Grant Applications		 Scientific Merit Review Advisory Council
Review		 Earliest Start Date

Participating Funding Organizations

Each funding opportunity specifies the participating organizations. Applications must fit within the mission of at least one participating funding organization and meet all opportunity-specific requirements.

The following funding organizations participate on at least one active funding opportunity.

  • National Institute of Allergy and Infectious Diseases (NIAID)
  • National Institute on Drug Abuse (NIDA)

This page last updated on: December 30, 2024
For technical issues E-mail OER Webmaster